Finerenone Reduces Renal RORγt γδ T Cells and Protects against Cardiorenal Damage

Luettges K.a,b· Bode M.c· Diemer J.N.c· Schwanbeck J.a,b· Wirth E.K.b,d· Klopfleisch R.e· Kappert K.f· Thiele A.a,b· Ritter D.a,b· Foryst-Ludwig A.a,b· Kolkhof P.g· Wenzel U.O.c· Kintscher U.a,b

Author affiliations

aCardiovascular Metabolic Renal Research Center, Institute of Pharmacology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany
bDZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany
cDepartment of Medicine III, University Hospital Hamburg Eppendorf, Hamburg, Germany
dDepartment of Endocrinology and Metabolism, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany
eDepartment of Veterinary Pathology, College of Veterinary Medicine, Freie Universität Berlin, Berlin, Germany
fInstitute of Diagnostic Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin Humboldt-Universität zu Berlin, Berlin, Germany
gBayer AG, Research & Early Development, Cardiovascular Research, Wuppertal, Germany

留言 (0)

沒有登入
gif